The growing global threat of antimicrobial resistance (often called “AR” in the U.S. and “AMR” elsewhere) was recognized by U.S. President Obama, Swedish Prime Minister and then-European Council President Reinfeldt, and European Commission President Barroso at the 2009 U.S.–EU summit. The summit declaration called for the establishment of “a transatlantic taskforce on urgent AMR issues focused on three key areas:
- Appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities,
- Prevention of both healthcare- and community-associated drug-resistant infections, and
- Strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us.”
The Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) was constituted based on this declaration.
TATFAR identified and adopted 17 recommendations for future collaborations between the U.S. and the EU. Collaboration between the U.S. and the EU has led to increased information exchange, understanding of best approaches and practices, and development of peer relationships. While significant progress has been made, concern related to AMR continues to escalate. Therefore, the mandate of the taskforce was extended for two additional years. In May 2014, the taskforce released a report summarizing the progress and the outcomes of the implementation of the 17 recommendations. The taskforce decided to continue with 15 recommendations, retiring two, and created one new recommendation for collaboration from 2014-2016.
In October, 2015 the TATFAR held an in-person meeting in Luxembourg and extended the collaboration for an additional five years (2016-2020).
CDC currently provides the secretariat for the taskforce and publishes documents relating to the work of the taskforce on this website. The European Centre for Disease Prevention and Control (ECDC) provided the secretariat from 2009-2013.
Learn more about TATFAR:
- Page last reviewed: February 3, 2016
- Page last updated: February 3, 2016
- Content source: